Conagra Brands (CAG) investors are prepared for a conservative fiscal 2027 outlook amid softer consumption trends and input-cost inflation, UBS Securities said Wednesday in a report.

UBS expects organic sales growth of 0.3%, compared with Wall Street expectations of 0.4%, and adjusted operating margins of 10.4% versus the 11% consensus, along with earnings per share of $1.50, or $0.13 below projections.

For fiscal Q4, UBS expects organic sales growth of 0.6%, compared with Wall Street's 0.9% estimate, with gains from the previous quarter in the grocery and snacks segment and the refrigerated and frozen unit. International organic sales may fall 2.5%, versus analysts' projected 0.5% decline, the report said.

Q4 results are due Wednesday.

UBS maintained its neutral rating on Conagra stock with a $13 price target.

Price: 13.55, Change: -0.23, Percent Change: -1.63